Status:
COMPLETED
Metachonous Peritoneal Carcinomatosis Incidence After Curative Surgery for pT4 Colon Cancer Patients
Lead Sponsor:
Carlos Cerdán Santacruz
Collaborating Sponsors:
Spanish Association of Surgeons (AEC)
Conditions:
Peritoneal Carcinomatosis
Colon Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This is an observational retrospective cohort study to determine metachronous peritoneal carcinomatosis in a specific subgroup of colon cancer patients, those with a final pathologic exam correspondin...
Detailed Description
This is an observational retrospective cohort study to determine metachronous peritoneal carcinomatosis in a specific subgroup of colon cancer patients, those with a final pathologic exam correspondin...
Eligibility Criteria
Inclusion
- Colon cancer above 15 cm from anal verge
- Curative intent surgery
- Pathologic confirmation of pT4 adenocarcinoma
Exclusion
- R2 cancer resection
- Inclusion in other randomized clinical trials
- Pathologic diagnosis of colon cancer other than adenocarcinoma, such as GIST, leiomyosarcomas, neuroendocrine tumors, or other types even more unusual.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 15 2021
Estimated Enrollment :
1152 Patients enrolled
Trial Details
Trial ID
NCT05300789
Start Date
March 1 2021
End Date
July 15 2021
Last Update
March 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Carlos Cerdán
Madrid, Spain